Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACTRN12621001143819Phase 2Not yet recruiting
Phase 2, randomised, open-label trial of lidocaine and epinephrine in postoperative pain, sponsored by Chris O'Brien Lifehouse. Primary endpoint: Post-operative pain score. Planned start Oct 2021; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ACTRN12621001143819.